Concord Medical Financials

CCM Stock  USD 7.73  0.27  3.37%   
Based on the analysis of Concord Medical's profitability, liquidity, and operating efficiency, Concord Medical Services may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Concord Medical's Total Liabilities is very stable compared to the past year. As of the 24th of October 2024, Property Plant Equipment is likely to grow to about 4.7 B, though Total Stockholder Equity is likely to grow to (2 B). Key indicators impacting Concord Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio0.30.3163
Notably Down
Slightly volatile
Investors should never underestimate Concord Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Concord Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Concord Medical Services.

Cash And Equivalents

230.78 Million

  
Understanding current and past Concord Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Concord Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Concord Medical's assets may result in an increase in income on the income statement.

Concord Medical Stock Summary

Concord Medical competes with Pennant, Encompass Health, Enhabit, National HealthCare, and American Shared. Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS2062771058
CUSIP206277105 206277204
LocationChina
Business AddressEast Zone, Hanwei
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.concordmedical.com
Phone86 10 5903 6688
CurrencyUSD - US Dollar

Concord Medical Key Financial Ratios

Concord Medical Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets4.3B5.3B6.2B6.0B6.1B4.0B
Other Current Liab274.7M243.2M301.1M325.2M674.1M707.8M
Other Liab287.0M270.2M230.1M268.9M309.2M324.7M
Cash74.3M334.3M157.4M158.3M58.1M55.2M
Other Assets661.1M409.9M250.6M24.0M27.6M26.2M
Long Term Debt1.3B2.0B2.2B2.5B2.0B2.1B
Good Will210.4M213.7M581.9M575.4M661.7M694.8M
Other Current Assets4.3M31.4M6.0M24.3M412.9M433.6M
Total Liab2.4B2.9B3.5B4.0B4.3B4.5B
Intangible Assets532.5M522.8M1.1B762.1M721.1M461.5M
Net Debt1.8B2.0B2.6B3.1B3.2B3.4B
Retained Earnings(1.8B)(2.5B)(3.3B)(3.8B)(4.1B)(3.9B)
Accounts Payable8.3M18.6M102.5M146.7M129.2M135.7M
Net Receivables199.6M280.4M383.0M512.8M73.5M69.8M
Total Current Assets282.5M676.0M584.5M759.8M617.2M736.9M
Short Term Debt341.3M162.5M319.8M548.5M1.1B1.1B
Inventory4.3M21.6M38.1M84.8M40.3M28.3M
Net Tangible Assets(865.7M)(1.4B)(2.6B)(2.8B)(2.5B)(2.4B)
Short Long Term Debt328.4M148.9M299.4M512.6M1.0B537.8M

Concord Medical Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense28.7M81.4M73.8M120.4M165.7M174.0M
Total Revenue198.4M223.0M485.6M472.1M537.4M458.0M
Gross Profit(15.8M)13.1M(56.9M)(152.4M)(76.6M)(72.8M)
Cost Of Revenue214.2M209.9M542.5M624.5M614.0M314.8M
Income Tax Expense(39.0M)(37.6M)(6.6M)(70.9M)(24.6M)(23.3M)
Operating Income(437.3M)(307.5M)(458.3M)(525.0M)(463.0M)(439.8M)
Ebit(437.3M)(307.5M)(435.5M)(714.0M)(442.2M)(420.1M)
Ebitda(263.6M)(206.4M)(331.4M)(581.2M)(313.7M)(298.1M)
Income Before Tax(391.1M)(441.7M)(529.2M)(839.9M)(555.6M)(527.8M)
Net Income(352.1M)(404.0M)(820.6M)(489.7M)(297.7M)(282.8M)
Minority Interest2.0B3.1B251.2M279.3M233.4M221.7M
Tax Provision(39.0M)(37.6M)(6.6M)(70.9M)(24.6M)(23.3M)
Interest Income10.4M8.4M5.9M10.0M10.8M18.1M
Net Interest Income(19.5M)(72.9M)(67.9M)(110.3M)(154.8M)(147.1M)

Concord Medical Key Cash Accounts

201920202021202220232024 (projected)
Capital Expenditures701.5M512.9M780.3M384.8M119.9M113.9M
End Period Cash Flow74.3M446.4M158.9M159.3M90.4M85.9M
Change To Netincome174.8M32.5M(145.4M)35.1M40.4M31.6M
Change To Inventory(1.8M)(14.4M)(4.4M)(46.8M)44.5M46.7M
Change In Cash(752.4M)372.1M(287.5M)432K(68.9M)(65.5M)
Free Cash Flow(896.8M)(742.7M)(1.1B)(601.5M)(396.4M)(416.2M)
Depreciation56.4M80.3M104.1M132.8M128.5M91.0M
Other Non Cash Items176.6M119.3M79.9M392.2M192.4M101.7M
Net Income(352.1M)(404.0M)(522.7M)(769.0M)(531.0M)(504.5M)
Investments(1.1B)(239.3M)(566.0M)(118.8M)(47.7M)(50.1M)
Net Borrowings523.3M353.1M245.5M383.1M440.6M286.7M

Concord Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Concord Medical's current stock value. Our valuation model uses many indicators to compare Concord Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Concord Medical competition to find correlations between indicators driving Concord Medical's intrinsic value. More Info.
Concord Medical Services is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Concord Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Concord Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Concord Medical Services Systematic Risk

Concord Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Concord Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Concord Medical Services correlated with the market. If Beta is less than 0 Concord Medical generally moves in the opposite direction as compared to the market. If Concord Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Concord Medical Services is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Concord Medical is generally in the same direction as the market. If Beta > 1 Concord Medical moves generally in the same direction as, but more than the movement of the benchmark.

Concord Medical Thematic Clasifications

Concord Medical Services is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
HealthcareView
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Concord Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Concord Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Concord Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.029

At this time, Concord Medical's Price Earnings To Growth Ratio is very stable compared to the past year.

Concord Medical October 24, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Concord Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Concord Medical Services. We use our internally-developed statistical techniques to arrive at the intrinsic value of Concord Medical Services based on widely used predictive technical indicators. In general, we focus on analyzing Concord Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Concord Medical's daily price indicators and compare them against related drivers.
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.21)
Revenue Per Share
107.978
Quarterly Revenue Growth
(0.23)
Return On Assets
(0.04)
Return On Equity
(0.32)
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.